• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?

0
  • by alexperjescuadmin
  • in Cardiovascular
  • — 6 Apr, 2007
Audio Journal of Cardiovascular Medicine: "COURAGE" Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?
AudioMedica News
Audio Journal of Cardiovascular Medicine: "COURAGE" Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?
Audio Journal of Cardiovascular Medicine: "COURAGE" Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?
00:00 /
RSS Feed
Share
Link
Embed
Harvey White

HARVEY WHITE, Auckland City Hospital

REFERENCE: ACC 2007 & N Engl J Med 356: March 2007
The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for patients with stable coronary disease, should give pause for thought among clinicians all over the world, according to Harvey White, who discussed the new data with Peter Goodwin.

[audio:https://www.audiomedica.com/podcasting/cardio/0704april/070407_harvey_white.mp3]
Share

Tags: angioplastycardiovascularcoronarycoronary diseasecourage trialharvey white

You may also like...

  • COMMENTS COMMENTS 16 Nov, 2005
  • Enoxaparin Shows Safety in Angioplasty – STEEPLE Study Enoxaparin Shows Safety in Angioplasty – STEEPLE Study 12 Sep, 2005
  • COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk 26 Mar, 2007
  • Telomere Length Predicts Coronary Heart Disease Risk and Statin Response Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Oncology in Advance – April 1st, 2007 – reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006
  • Next story Audio Journal of Oncology in Advance – April 15th, 2007 – Bisphosphonates Recommended for Lung Cancer Bone Metastases
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with…
    • Which New Combination for Metastatic Renal Cell Cancer?
  • Home
  • Cardiovascular
  • Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.